Changes in outcome measures across placebo and testosterone arms and the open label extension arm.
Results are presented as raw number, p value and 95% confidence intervals (lower, upper). Bolded results have significant 95% CI. Placebo = placebo phase, when the participants were provided with the placebo (either 0–12 weeks or 14–26 weeks depending on the participant). Testosterone = testosterone phase, when the participans were provided with testosterone (either 0–12 weeks or 14–26 weeks depending on the participant). OLE = open label extension. Difference Placebo / Testosterone refers to the difference between the placebo and testosterone phase of the trial. Difference end of study and OLE refers to the difference between the week 26 and the OLE 12 months result; and is presented in 95% CI and p values. Between the placebo and the testosterone phase was a wash out period. Nm = Newton meters, sec = seconds, kg = kilograms, cm = centimetre, m = meter. As not all participants were able to perform all outcome measures, n refers to the number of individuals analysed in each arm.